June 18, 2019 – GNA Biosolutions has been awarded a place in the 2019 MedTech Innovator Showcase, which features leading-edge device, diagnostic, and digital health technologies from around the world.
Each year, MedTech Innovator recognizes the 50 best-in-class startups across the medtech industry. Startups selected for this honor receive a slot in the MedTech Innovator Showcase.
This year’s competition attracted a record-breaking number of applications, with more than 800 companies applying. Applications were reviewed by more than 150 executives and professionals from dozens of leading companies including Johnson & Johnson, RCT Ventures, Baxter, BTG, HOYA Corp, NIPRO Medical Corp., Olympus Medical Systems Group, W.L Gore & Associates, Inc. and many more.
MedTech Innovator is a premier nonprofit startup accelerator in the medical technology industry. MedTech Innovator’s 2019 program includes participation from the U.S. military, National Institutes of Health (NIH), Food and Drug Administration (FDA), and Biomedical Advanced Research and Development Authority (BARDA), as well as leading healthcare investors, manufacturers, providers, hospital systems, and payers.
As part of the program, GNA Biosolutions will be presenting at the MedTech Innovator Showcase held in conjunction with The Wilson Sonsini Goodrich & Rosati Medical Device Conference taking place June 20-21 in San Francisco, and The MedTech Conference on Sept. 23-25 in Boston.
“The MedTech Innovator competition is a unique and exciting opportunity for us showcase our company and award-winning PCA technology,” said Anastasia Liapis, Head of Strategic Marketing & Partnerships at GNA Biosolutions. “We are honored to be included amongst this group of innovative companies.”